Science

Studying the mechanisms of LCH using an innovative model based on iPSCs – St. Anna CCRI

St. Anna CCRI/LinkedIn

Feb 24, 2025, 13:14

Studying the mechanisms of LCH using an innovative model based on iPSCs – St. Anna CCRI

St. Anna Children’s Cancer Research Institute (CCRI) shared an article by Giulio Abagnale, et al. on LinkedIn:

“Our latest research has made it to the cover of Blood!

Not only that, but it also received a Blood Commentary, highlighting its significance in the field.

Using an innovative model based on induced pluripotent stem cells (iPSCs), the team from St. Anna CCRI were able to comprehensively study the mechanisms of LCH for the first time.

Read the full paper here.

A huge congratulations to the team for this achievement!”

BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responses

Authors: Giulio Abagnale, et al.

Studying the mechanisms of LCH using an innovative model based on iPSCs - St. Anna CCRI

Blood Commentary Blood Journal cancer fight against cancer Giulio Abagnale Global awareness Global fight against cancer iPSCs LCH OncoDaily Oncology St. Anna CCRI St. Anna Children's Cancer Research Institute

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC